Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00775229 · ClinicalTrials.gov registry record · Phase 2
Naltrexone in the Treatment of Trichotillomania
A Phase 2 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 51
- Enrollment target
NCT00775229 is a Phase 2 study that has completed, run by University of Chicago. The registered enrollment target is 51 participants.
The verdict
NCT00775229, a Phase 2 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 51 participants
- Enrollment target
Study Summary
This is an 8-week, double-blind study of Natrexone in the treatment of trichotillomania
Interventions
- DRUG Placebo
- DRUG Naltrexone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2008-08 |
| Est. Completion | 2012-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00775229
The ClinicalTrials.gov registry entry for NCT00775229 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00775229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00775229 about?
NCT00775229 is a clinical study titled "Naltrexone in the Treatment of Trichotillomania". This is an 8-week, double-blind study of Natrexone in the treatment of trichotillomania
What is the current status of trial NCT00775229?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 51 participants. The study started on 2008-08. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00775229?
The interventions under investigation include: Placebo (DRUG), Naltrexone (DRUG).
Who is sponsoring clinical trial NCT00775229?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.